dr. viprakasit on the utility of luspatercept in beta-thalassemia
Published 4 years ago • 491 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
0:44
dr. patel on the clinical implications of luspatercept approval in mds
-
3:01
long-term results of believe: luspatercept in adults with transfusion-dependent beta-thalassemia
-
7:08
believe: β-thalassemia treatment with luspatercept reduces transfusion burden
-
2:35
long-term results of the believe study: luspatercept in patients with beta-thalassemia
-
4:05
impact of β-thalassemia on the providers
-
2:02
beyond trial update: luspatercept in non-transfusion-dependent β-thalassemia
-
0:55
luspatercept lowers the transfusion burden in patients with myelofibrosis-associated anemia
-
10:55
relieving the transfusion burden | the experience of ali inbrahim with luspatercept
-
5:56
future impact of the novel therapy for beta-thalassemia
-
7:17
beta-thalassemia - causes, symptoms, diagnosis, treatment, pathology
-
1:26
durable symptom improvement in ntd thalassemia treated with luspatercept in the beyond trial
-
1:00
luspatercept and mitapivat for the treatment of patients with beta-thalassemia
-
1:39
luspatercept in patients with hbe/β‑thalassemia: a subgroup analysis from the believe study
-
5:33
luspatercept reduces transfusion burden in β-thalassemia
-
5:48
thalassemia: alpha & beta-thalassemias, genetics, pathophysiology, diagnosis & treatment, animation
-
4:24
luspatercept benefits mf-associated anemia
-
8:15
current approaches for beta-thalassemia
-
6:58
maria domenica cappellini: the believe trial: luspatercept in adult beta-thalassemia
-
4:20
overview of β-thalassemia